Jennifer K. Richer
Affiliations: | University of Colorado Anschutz Medical Campus, Denver, Aurora, CO |
Area:
Oncology, Cell Biology, Molecular BiologyGoogle:
"Jennifer Richer"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Welter L, Zheng S, Setayesh SM, et al. (2023) Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-Omics. Cancers. 15 |
| Fernández NB, Sosa SM, Roberts JT, et al. (2023) RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer. Cells. 12 |
| Porman AM, Roberts JT, Duncan ED, et al. (2022) A single N6-methyladenosine site regulates lncRNA HOTAIR function in breast cancer cells. Plos Biology. 20: e3001885 |
| Camp FA, Brunetti TM, Williams MM, et al. (2022) Antigens Expressed by Breast Cancer Cells Undergoing EMT Stimulate Cytotoxic CD8 T Cell Immunity. Cancers. 14 |
| O'Neill KI, Kuo LW, Williams MM, et al. (2022) NPC1 Confers Metabolic Flexibility in Triple Negative Breast Cancer. Cancers. 14 |
| Li Z, Spoelstra NS, Sikora MJ, et al. (2022) Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer. Npj Breast Cancer. 8: 62 |
| Li Z, McGinn O, Wu Y, et al. (2022) ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation. Nature Communications. 13: 2011 |
| Li Z, Wu Y, Yates ME, et al. (2022) Hotspot ESR1 mutations are multimodal and contextual modulators of breast cancer metastasis. Cancer Research |
| Williams MM, Hafeez SA, Christenson JL, et al. (2021) Reversing an Oncogenic Epithelial-to-Mesenchymal Transition Program in Breast Cancer Reveals Actionable Immune Suppressive Pathways. Pharmaceuticals (Basel, Switzerland). 14 |
| Hanamura T, Christenson JL, O'Neill KI, et al. (2021) Secreted indicators of androgen receptor activity in breast cancer pre-clinical models. Breast Cancer Research : Bcr. 23: 102 |